ro glp-1 supply tracker 2025 Insurance Coverage Checker Report Digital health company Ro launches

While the long-term safety of ipamorelin has yet to be evaluated, we can surmise that, as a growth hormone (GH) secretagogue, long-term ipamorelin therapy may indirectly produce side effects associated with elevated GH levels

While its available as a research chemical, it cannot be prescribed by doctors or peptide clinics

Some reports of persistent GI problems after stopping the drug are also circulating, though its difficult to establish causality from individual reports

BRASS et al, 1994, VUKOVICH et al, 1994

Altan E, Masaoka T, Farr R, Tack J

Many patients begin to notice reduced appetite and improved portion control within the first few weeks